Brooklyn, NY, October 17th, 2019

scite, a deep learning platform that allows anyone to see how a scientific report has been evaluated by subsequent studies, and Future Science Group (FSG), a publisher focused on breakthrough medical, biotechnological and scientific research, have partnered to provide scite analytics to the readers of BioTechniques, an FSG journal.

Each BioTechnique article now displays a badge indicating how many times the article has been supported, contradicted, or mentioned in the scientific literature. Clicking on the badge brings the reader a report that includes citation contexts and the ability to quickly select citations that support or contradict the article. As a result, the readers of BioTechniques can now evaluate published research much quicker and with more confidence.

scite’s analytics are currently based on 420M citation contexts that have been extracted from 12M scientific publications and cite 31M articles, with the company aiming at processing all scientific publications.

Phil Garner, CEO of Future Science Group says, “scite has found a novel way to make citations more informative and we’re happy to partner with them to help identify and promote reliable research. We will use the results from this pilot to determine how we can expand scite analytics to other journals in our portfolio.”

Josh Nicholson, co-founder and CEO of scite adds, “We’re happy to be working with Future Science Group and the BioTechniques team. BioTechniques has a long track record of publishing innovative and important methods in life sciences. As a recent PhD grad myself I understand how difficult it can be to track down the right protocol and make sure it is reliable. By making variations in methods across groups more discoverable and helping researchers identify which are most reliable we think this partnership marks an important milestone towards making research more reliable.”

About scite

scite is a Brooklyn-based startup that enables anyone to see how a scientific report has been cited, specifically if it has been supported or contradicted. scite is used by researchers from dozens of countries and has been funded in part by the National Science Foundation and the National Institutes of Health.

About Future Science Group

Founded in 2001, FSG is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG’s portfolio consists of three imprints, Future Medicine, Future Science and Newlands Press, publishing both eBooks and journals. In addition to this core publishing business, FSG develops specialist knowledge networks and content hubs, enabling professionals to easily connect and collaborate with their peers in niche scientific fields. FSG currently publishes 34 peer-reviewed journals as well as 8 knowledge networks and content hubs across a wide range of therapy area and scientific fields. Key journals include Future Microbiology, Future Oncology and the Journal of Comparative Effectiveness Research, alongside sites such as Infectious Diseases Hub, Oncology Central and The Evidence Base.